Delta 9 Cannabis Inc. (DN.TO) Research

Delta 9 Cannabis Inc. is a diversified enterprise operating across various segments of the cannabis industry. Its subsidiary, Delta 9 Bio-Tech Inc., handles the cultivation, processing, extraction, and distribution of both medicinal and recreational cannabis products, managing both wholesale and retail channels. The product portfolio spans dried cannabis flower, pre-rolled joints, dried sift, various oils, and a range of extracted and derivative offerings; notably, they also provide decontamination pods. Furthermore, Delta 9 supplies grow pods and live cannabis plants to other businesses, including those already licensed and those awaiting licensure. Beyond product sales, the company runs a medical clinic where physicians offer consultations to patients looking for a medical recommendation for cannabis prescriptions. As of April 20, 2022, Delta 9 operated a network of 35 branded retail outlets throughout the Canadian Prairies. Established in 2001, its corporate headquarters are located in Winnipeg, Canada.

Market snapshot

Symbol
DN.TO
Price
$0.01
Day change
-50.00%
Market cap
$1.5M
P/E ratio
-0.05x
52-week range
0.005-0.07
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Canada House Cannabis Group Inc. (CHV.CN)
  • Entourage Health Corp. (ENTG.V)
  • New Leaf Ventures Inc (NLV.CN)
  • Orchid Ventures, Inc. (ORCD.CN)
  • Origin Therapeutics Holdings Inc. (ORIG.CN)
  • The Hash Corporation (REZN.CN)
  • Silo Wellness Inc. (SILO.CN)
  • SLANG Worldwide Inc. (SLNG.CN)

Open Delta 9 Cannabis Inc. (DN.TO) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.